TREOS BIO
Treos Bio, Inc. is a computational immunology and immunotherapy company which has developed a proprietary technology to predict in silico likely responders to cancer immunotherapies and to design in silico next generation targeted immunotherapies for a large population of cancer patients.
TREOS BIO
Social Links:
Industry:
Biotechnology Clinical Trials Health Care Health Diagnostics Therapeutics
Founded:
2013-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.treosbio.com
Total Employee:
11+
Status:
Active
Contact:
+44-20-3141 7370
Email Addresses:
[email protected]
Total Funding:
24.42 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API WordPress Google Analytics LetsEncrypt SSL By Default Font Awesome
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
ASC Oncology
ASC Oncology offers reverse clinical engineering to support patients and physicians.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
GammaDelta Therapeutics
GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells
Médipole Garonne
Médipole Garonne Clinic, focused on orthopedic surgery and care of the athlete, has reached its phase of maturity.
OmiCure
OmiCure helps clinicians choose therapy and diet for cancer patients.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Employees Featured
Founder
Investors List
The Future Fund
The Future Fund investment in Convertible Note - Treos Bio
Luminous Ventures
Luminous Ventures investment in Convertible Note - Treos Bio
BXR Partners LLP
BXR Partners LLP investment in Venture Round - Treos Bio
Official Site Inspections
http://www.treosbio.com
- Host name: 192-185-20-113.unifiedlayer.com
- IP address: 192.185.20.113
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Treos Bio"
Treos Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +44-20-3141 7370 Treos Bio, Inc. is a computational immunology and immunotherapy company which has developed a proprietary technology to predict in silico likely responders to …See details»
Treos Bio Limited | Company
1st Floor 40-44 Newman Street London W1T 1QD England Phone: +44-20-3141 7370 Email: [email protected]See details»
TREOS BIO LIMITED Overview | SignalHire Company Profile
Jul 21, 2023 Organization Website: treosbio.com : Social Links: Phone Number: 44-20-3141-7370: TREOS BIO LIMITED industries Biotech, Pharmaceuticals, Biotechnology: …See details»
Treos Bio Company Profile 2024: Valuation, Funding & Investors
Treos Bio General Information Description. Operator of a clinical-stage biotechnology company intended to change the paradigm of cancer immunotherapy development. The company uses …See details»
TREOS BIO LIMITED Company Profile - Dun & Bradstreet
TREOS BIO LIMITED Company Profile | LONDON, United Kingdom | Competitors, Financials & Contacts - Dun & BradstreetSee details»
TREOS BIO - LinkedIn
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of …See details»
Treos Bio Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Jul 1, 2023 Sign Up for Free. Last update 01 Nov 2024See details»
Treos Bio - Company Profile - Tracxn
Nov 1, 2024 Treos Bio - Developer of cancer vaccines and companion diagnostics. Raised a total funding of $22M over 2 rounds from 7 investors. Valued at $45.2M. Founded by John …See details»
TREOS BIO LIMITED Information - RocketReach
Treosbio.com; View Similar People. Related Companies Peppy. 149 $5.3m Plus-Project Partnership. 74 $1m Business in Wales. 193 NRS Healthcare. 20 $127m Numan. 264 …See details»
Treos Bio - Overview, News & Similar companies | ZoomInfo.com
Popular Searches TREOS BIO Ltd Treos Bio Inc Treos Bio Corp Treos Bio Treosbio SIC Code 87,873 NAICS Code 54,541 Show more. Treos Bio Org Chart. Phone Email. Christopher …See details»
Treos Bio Limited | Leadership
Dr. Gallen then became President of the nascent Premier Research Worldwide (PRWW) and with great staff innovated the first use of Remote Data Capture into the Clinical Research …See details»
Treos Bio, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Treos Bio, Inc. of Bethesda, MD. Get the latest business insights from Dun & Bradstreet.See details»
Treos Bio Ltd. (Treos Bio Ltd.) - 药物管线_专利_临床试验_投融营 …
The Company is also developing off-the-shelf immunotherapies personalized to an individual patient’s HLA genotype for several types of solid tumors. Treos has raised $45 million to date. …See details»
Treos Bio Limited | Home
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of …See details»
Treos Bio - Craft
Treos Bio is a company that uses its cancer vaccine technology to develop precision cancer immunotherapy. These therapies are peptide vaccines that induce potent immune responses …See details»
Treos Bio to Present New Clinical Data on Off-the-Shelf
LONDON and BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Treos Bio, a clinical stage biotechnology company using data science and proprietary biomarkers to develop precision …See details»
Treos Bio Limited | May 8, 2024
May 8, 2024 1st Floor 40-44 Newman Street London W1T 1QD England Phone: +44-20-3141 7370 Email: [email protected]See details»
Treos Bio Limited | Platform
1st Floor 40-44 Newman Street London W1T 1QD England Phone: +44-20-3141 7370 Email: [email protected]See details»
Treos Bio Limited | Press releases
Feb 7, 2022 Treos Bio to Present New Clinical Data on Off-the-Shelf Peptide Immunotherapy for Colorectal Cancer at 2024 ASCO Annual Meeting . LONDON and BOSTON – May 8, 2024– …See details»